Cell tracing reveals the transdifferentiation fate of mouse lung epithelial cells during pulmonary fibrosis <em>in vivo</em>

Tan,Wei; Wang,Yaru; Chen,Yuhua; Chen,Cheng

doi:10.3892/etm.2021.10622

Cell tracing reveals the transdifferentiation fate of mouse lung epithelial cells during pulmonary fibrosis in vivo

Authors:
- Wei Tan
- Yaru Wang
- Yuhua Chen
- Cheng Chen
View Affiliations

Affiliations: Department of Developmental Cell Biology, Key Laboratory of Cell Biology of The Ministry of Public Health, Key Laboratory of Medical Cell Biology of The Ministry of Education, China Medical University, Shenyang, Liaoning 110122, P.R. China
Published online on: August 17, 2021 https://doi.org/10.3892/etm.2021.10622
Article Number: 1188
Copyright: © Tan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and devastating interstitial lung disease. The origin of myofibroblasts is still to be elucidated and the existence of epithelial‑mesenchymal transition (EMT) in IPF remains controversial. Hence, it is important to clarify the origin of fibroblasts by improving modeling and labeling methods and analyzing the differentiation pathway of alveolar epithelial cells (AEC) in pulmonary fibrosis with cell tracking technology. In the present study, adult transgenic mice with SPC‑rtTA^+/‑/tetO₇‑CMV‑Cre^+/‑/mTmG^+/‑ were induced with doxycycline for 15 days. The gene knockout phenomenon occurred in type II AECs in the lung and the reporter gene cell membrane‑localized enhanced green fluorescence protein (mEGFP) was expressed in the cell membrane. The expression of Cre recombinase and SPC was analyzed using immunohistochemical (IHC) staining to detect the labeling efficiency. A repetitive intraperitoneal bleomycin‑induced pulmonary fibrosis model was established, and the mice were sacrificed on day 28. The co‑localization of mEGFP and mesenchymal markers α‑smooth muscle actin (α‑SMA) and S100 calcium binding protein A4 (S100A4) were detected by multiple IHC staining. The results revealed that Cre was expressed in the airway and AECs in the lung tissue of adult transgenic mice with SPC‑rtTA^+/‑/tetO₇‑CMV‑Cre^+/‑/mTmG^+/‑ induced by doxycycline; the labeling efficiency in the peripheral lung tissue was 63.27±7.51%. mEGFP was expressed on the membrane of type II AECs and their differentiated form of type I AECs. Expression of mEGFP was mainly observed in the fibrotic region in bleomycin‑induced pulmonary fibrosis; 1.94±0.08% of α‑SMA‑positive cells were mEGFP‑positive and 9.68±2.06% of S100A4‑positive cells were mEGFP‑positive in bleomycin‑induced pulmonary fibrosis. In conclusion, the present results suggested that while EMT contributes to the pathogenesis of pulmonary fibrosis, it is not the major causative factor of this condition.

View Figures

View References

1	Barratt SL, Creamer A, Hayton C and Chaudhuri N: Idiopathic pulmonary fibrosis (IPF): An overview. J Clin Med. 7(201)2018.PubMed/NCBI View Article : Google Scholar
2	Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, et al: Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 198:e44–e68. 2018.PubMed/NCBI View Article : Google Scholar
3	Richeldi L, Collard HR and Jones MG: Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017.PubMed/NCBI View Article : Google Scholar
4	Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, et al: Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 179:588–594. 2009.PubMed/NCBI View Article : Google Scholar
5	Selman M and Pardo A: The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. Cell Signal. 66(109482)2020.PubMed/NCBI View Article : Google Scholar
6	Nieto MA, Huang RY, Jackson RA and Thiery JP: EMT: 2016. Cell. 166:21–45. 2016.PubMed/NCBI View Article : Google Scholar
7	Salton F, Ruaro B, Confalonieri P and Confalonieri M: Epithelial-mesenchymal transition: A major pathogenic driver in idiopathic pulmonary fibrosis? Medicina (Kaunas). 56(608)2020.PubMed/NCBI View Article : Google Scholar
8	Salton F, Volpe MC and Confalonieri M: Epithelial-mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis. Medicina (Kaunas). 55(83)2019.PubMed/NCBI View Article : Google Scholar
9	Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D and Chapman HA: Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA. 103:13180–13185. 2006.PubMed/NCBI View Article : Google Scholar
10	DeMaio L, Buckley ST, Krishnaveni MS, Flodby P, Dubourd M, Banfalvi A, Xing Y, Ehrhardt C, Minoo P, Zhou B, et al: Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. J Pathol. 226:633–644. 2012.PubMed/NCBI View Article : Google Scholar
11	Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA and Chapman HA: Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest. 119:213–224. 2009.PubMed/NCBI View Article : Google Scholar
12	Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W, Sherrill TP, Plieth D, Neilson EG, Blackwell TS and Lawson WE: Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 180:657–665. 2009.PubMed/NCBI View Article : Google Scholar
13	Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS and Lawson WE: Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 299:L442–L452. 2010.PubMed/NCBI View Article : Google Scholar
14	Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, Boomershine CS, Ortiz C, Sherrill TP, McMahon FB, Gleaves LA, et al: TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment. Am J Physiol Lung Cell Mol Physiol. 300:L887–L897. 2011.PubMed/NCBI View Article : Google Scholar
15	Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW and Hogan BL: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA. 108:E1475–E1483. 2011.PubMed/NCBI View Article : Google Scholar
16	Chilosi M, Caliò A, Rossi A, Gilioli E, Pedica F, Montagna L, Pedron S, Confalonieri M, Doglioni C, Ziesche R, et al: Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. Mod Pathol. 30:26–38. 2017.PubMed/NCBI View Article : Google Scholar
17	Harada T, Nabeshima K, Hamasaki M, Uesugi N, Watanabe K and Iwasaki H: Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: Quantitative immunohistochemistry. Pathol Int. 60:14–21. 2010.PubMed/NCBI View Article : Google Scholar
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
19	Boye K and Maelandsmo GM: S100A4 and metastasis: A small actor playing many roles. Am J Pathol. 176:528–535. 2010.PubMed/NCBI View Article : Google Scholar
20	B Moore B, Lawson WE, Oury TD, Sisson TH, Raghavendran K and Hogaboam CM: Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol. 49:167–179. 2013.PubMed/NCBI View Article : Google Scholar
21	Mouratis MA and Aidinis V: Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med. 17:355–361. 2011.PubMed/NCBI View Article : Google Scholar
22	Moore BB and Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 294:L152–L160. 2008.PubMed/NCBI View Article : Google Scholar
23	Degryse AL and Lawson WE: Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci. 341:444–449. 2011.PubMed/NCBI View Article : Google Scholar
24	Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, et al: Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol. 167:1267–1277. 2005.PubMed/NCBI View Article : Google Scholar
25	Adamson IY and Bowden DH: The pathogenesis of bloemycin-induced pulmonary fibrosis in mice. Am J Pathol. 77:185–197. 1974.PubMed/NCBI
26	Yoldas O, Karaca T, Bilgin BC, Yilmaz OH, Simsek GG, Alici IO, Uzdogan A, Karaca N, Akin T, Yoldas S and Akbiyik F: Tamoxifen citrate: A glimmer of hope for silicosis. J Surg Res. 193:429–434. 2015.PubMed/NCBI View Article : Google Scholar
27	El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Szibor M, Kosanovic D, Schwind F, Schermuly RT, et al: Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis. Cell Stem Cell. 20:261–273.e3. 2017.PubMed/NCBI View Article : Google Scholar
28	Perl AK, Wert SE, Nagy A, Lobe CG and Whitsett JA: Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA. 99:10482–10487. 2002.PubMed/NCBI View Article : Google Scholar
29	Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, Oberg AL, Birch J, Salmonowicz H, Zhu Y, et al: Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 8(14532)2017.PubMed/NCBI View Article : Google Scholar
30	Chen X, Xu H, Hou J, Wang H, Zheng Y, Li H, Cai H, Han X and Dai J: Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. Aging (Albany NY). 12:242–259. 2019.PubMed/NCBI View Article : Google Scholar
31	Pirici D, Mogoanta L, Kumar-Singh S, Pirici I, Margaritescu C, Simionescu C and Stanescu R: Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype. J Histochem Cytochem. 57:567–575. 2009.PubMed/NCBI View Article : Google Scholar
32	Bolognesi MM, Manzoni M, Scalia CR, Zannella S, Bosisio FM, Faretta M and Cattoretti G: Multiplex staining by sequential immunostaining and antibody removal on routine tissue sections. J Histochem Cytochem. 65:431–444. 2017.PubMed/NCBI View Article : Google Scholar
33	Borensztajn K, Crestani B and Kolb M: Idiopathic pulmonary fibrosis: From epithelial injury to biomarkers-insights from the bench side. Respiration. 86:441–452. 2013.PubMed/NCBI View Article : Google Scholar
34	Bagnato G and Harari S: Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev. 24:102–114. 2015.PubMed/NCBI View Article : Google Scholar
35	Yamaguchi M, Hirai S, Tanaka Y, Sumi T, Miyajima M, Mishina T, Yamada G, Otsuka M, Hasegawa T, Kojima T, et al: Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis. Lab Invest. 97:232–242. 2017.PubMed/NCBI View Article : Google Scholar
36	Xia H, Gilbertsen A, Herrera J, Racila E, Smith K, Peterson M, Griffin T, Benyumov A, Yang L, Bitterman PB and Henke CA: Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis. J Clin Invest. 127:2586–2597. 2017.PubMed/NCBI View Article : Google Scholar
37	Lee JU, Chang HS, Shim EY, Park JS, Koh ES, Shin HK, Park JS and Park CS: The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis. Respir Med. 171(105945)2020.PubMed/NCBI View Article : Google Scholar